| Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes The ADVANCE Collaborative Group, A Patel N Engl J Med 358 (24), 2560-2572, 2008 | 10021* | 2008 |
| Canagliflozin and cardiovascular and renal events in type 2 diabetes B Neal, V Perkovic, KW Mahaffey, D De Zeeuw, G Fulcher, N Erondu, ... New England Journal of Medicine 377 (7), 644-657, 2017 | 7695 | 2017 |
| International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy: response to Weinert BE Metzger, SG Gabbe, B Persson, LP Lowe, AR Dyer, JJN Oats, ... Diabetes care 33 (7), e98-e98, 2010 | 5739 | 2010 |
| Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a … A Patel The Lancet 370 (9590), 829-840, 2007 | 3215 | 2007 |
| Islet β cell failure in type 2 diabetes M Prentki, CJ Nolan The Journal of clinical investigation 116 (7), 1802-1812, 2006 | 2286 | 2006 |
| Type 2 diabetes across generations: from pathophysiology to prevention and management CJ Nolan, P Damm, M Prentki The Lancet 378 (9786), 169-181, 2011 | 1293 | 2011 |
| Follow-up of blood-pressure lowering and glucose control in type 2 diabetes S Zoungas, J Chalmers, B Neal, L Billot, Q Li, Y Hirakawa, H Arima, ... New England Journal of Medicine 371 (15), 1392-1406, 2014 | 816 | 2014 |
| Saturated fatty acids synergize with elevated glucose to cause pancreatic β-cell death W El-Assaad, J Buteau, ML Peyot, C Nolan, R Roduit, S Hardy, E Joly, ... Endocrinology 144 (9), 4154-4163, 2003 | 763 | 2003 |
| Gestational diabetes mellitus--management guidelines L Hoffman, C Nolan, D Simmons The Medical Journal of Australia 169 (2), 93-97, 1998 | 692 | 1998 |
| Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial FIELD Study Investigators The Lancet 366 (9500), 1849-1861, 2005 | 547 | 2005 |
| Fatty acid signaling in the β-cell and insulin secretion CJ Nolan, MSR Madiraju, V Delghingaro-Augusto, ML Peyot, M Prentki Diabetes 55 (Supplement_2), S16-S23, 2006 | 516 | 2006 |
| Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre … RE Pratley, MA Nauck, AH Barnett, MN Feinglos, F Ovalle, ... The lancet Diabetes & endocrinology 2 (4), 289-297, 2014 | 363 | 2014 |
| Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes ER Mathiesen, M Hod, M Ivanisevic, S Duran Garcia, L Brøndsted, ... Diabetes care 35 (10), 2012-2017, 2012 | 292 | 2012 |
| Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift CJ Nolan, M Prentki Diabetes and Vascular Disease Research 16 (2), 118-127, 2019 | 278 | 2019 |
| Insulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetes CJ Nolan, NB Ruderman, SE Kahn, O Pedersen, M Prentki Diabetes 64 (3), 673-686, 2015 | 267 | 2015 |
| A role for the malonyl-CoA/long-chain acyl-CoA pathway of lipid signaling in the regulation of insulin secretion in response to both fuel and nonfuel stimuli R Roduit, C Nolan, C Alarcon, P Moore, A Barbeau, ... Diabetes 53 (4), 1007-1019, 2004 | 239 | 2004 |
| The fetal glucose steal: an underappreciated phenomenon in diabetic pregnancy G Desoye, CJ Nolan Diabetologia 59 (6), 1089-1094, 2016 | 210 | 2016 |
| The islet β-cell: fuel responsive and vulnerable CJ Nolan, M Prentki Trends in Endocrinology & Metabolism 19 (8), 285-291, 2008 | 204 | 2008 |
| Clinical and histological correlations of decline in renal function in diabetic patients with proteinuria JL Taft, CJ Nolan, SP Yeung, TD Hewitson, FI Martin Diabetes 43 (8), 1046-1051, 1994 | 186 | 1994 |
| Beta cell compensation for insulin resistance in Zucker fatty rats: increased lipolysis and fatty acid signalling CJ Nolan, JL Leahy, V Delghingaro-Augusto, J Moibi, K Soni, ML Peyot, ... Diabetologia 49, 2120-2130, 2006 | 171 | 2006 |
